1. Birkmayer, W., Riederer, P., Youdim, M. B. H., Linauer, W. The potentiation of the anti-akinetic effect after L-DOPA treatment by an inhibitor of MAO-B, deprenyl. J. Neural Transm.36, 303?326 (1975).
2. Birkmayer, W., Riederer, P., Ambrozi, L., Youdim, M. B. H. Implications of combined treatment with Madopar® and deprenil in Parkinson's disease: a long-term study. Lanceti, 434?443 (1977).
3. Glover, V., Sandler, M., Owen, F., Riley, G. J. Dopamine is a monoamine oxidase B substrate in man. Nature (London)265, 80?81 (1977).
4. Knoll, J., Vizi, E. S., Somogyi, G. Phenylisopropylmethylpropinylamine (E-250) a monoamino oxidase inhibitor antagonizing the effects of tyramine. Arzneimittelforschung18, 109?112 (1968).
5. Lees, A. J., Shaw, K. M., Kohout, L. J., Stern, G. M., Elsworth, J. D., Sandler, M., Youdim, M. B. H. Deprenyl in Parkinson's disease. Lancetii, 791?796 (1977).